Maternal Docosahexaenoic Acid Supplementation Alters Maternal and Fetal Docosahexaenoic Acid Status and Placenta Phospholipids in Pregnancies Complicated by High Body Mass Index
Nutrients · 2024
DOI: 10.3390/nu16172934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Katie L Bidne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Obstetrics and Gynecology, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Dietary Supplements, Placenta, Body Mass Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, training grant.
Abstract (Originalsprache)
Introduction
An optimal fetal supply of docosahexaenoic acid (DHA) is critical for normal brain development. The relationship between maternal DHA intake and DHA delivery to the fetus is complex and is dependent on placental handling of DHA. Little data exist on placental DHA levels in pregnancies supplemented with the recommended dose of 200 mg/d. Our objective was to determine how prenatal DHA at the recommended 200 mg/d impacts maternal, placental, and fetal DHA status in both normal-weight and high-BMI women compared to women taking no supplements.
Methods
Maternal blood, placenta, and cord blood were collected from 30 healthy pregnant women (BMI 18.9–43.26 kg/m2) giving birth at term. Red blood cells (RBCs) and villous tissue were isolated, and lipids were extracted to determine DHA content by LC-MS/MS. Data were analyzed by supplement group (0 vs. 200 mg/d) and maternal BMI (normal weight or high BMI) using two-way ANOVA. We measured maternal choline levels in maternal and cord plasma samples.
Results
Supplementation with 200 mg/d DHA significantly increased (p < 0.05) maternal and cord RBC DHA content only in pregnancies complicated by high BMI. We did not find any impact of choline levels on maternal or cord RBC phospholipids. There were no significant differences in total placental DHA content by supplementation or maternal BMI (p > 0.05). Placental levels of phosphatidylinositol (PI) and phosphatidic acid containing DHA species were higher (p < 0.05) in high-BMI women without DHA supplementation compared to both normal-BMI and high-BMI women taking DHA supplements.
Conclusion
Maternal DHA supplementation at recommended doses cord increased RBC DHA content only in pregnancies complicated by higher BMI. Surprisingly, we found that obesity was related to an increase in placental PI and phosphatidic acid species, which was ameliorated by DHA supplementation. Phosphatidic acid activates placental mTOR, which regulates amino acid transport and may explain previous findings of the impact of DHA on placental function. Current recommendations for DHA supplementation may not be achieving the goal of improving fetal DHA levels in normal-weight women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Obstetrics and Gynecology, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.
- Departments of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.
- Departments of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.
ORCID-Profile: Katie L Bidne, Karin Zemski Berry, Mairead Dillon, Thomas Jansson
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- training grant
- Colorado Nutrition Obesity Research Center
- NIH HHS
- NIH
- training grant in Nutrition
Zitieren
APA
Bidne, K. L., Zemski Berry, K., Dillon, M., Jansson, T., & Powell, T. L. (2024). Maternal Docosahexaenoic Acid Supplementation Alters Maternal and Fetal Docosahexaenoic Acid Status and Placenta Phospholipids in Pregnancies Complicated by High Body Mass Index. Nutrients. https://doi.org/10.3390/nu16172934
Vancouver
Bidne KL, Zemski Berry K, Dillon M, Jansson T, Powell TL. Maternal Docosahexaenoic Acid Supplementation Alters Maternal and Fetal Docosahexaenoic Acid Status and Placenta Phospholipids in Pregnancies Complicated by High Body Mass Index. Nutrients. 2024. doi:10.3390/nu16172934
BibTeX
@article{Bidne2024,
author = {Bidne, Katie L and Zemski Berry, Karin and Dillon, Mairead and Jansson, Thomas and Powell, Theresa L},
title = {Maternal Docosahexaenoic Acid Supplementation Alters Maternal and Fetal Docosahexaenoic Acid Status and Placenta Phospholipids in Pregnancies Complicated by High Body Mass Index},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16172934}
}
EUVIMED